AG-013736 In Combination With Docetaxel Versus Docetaxel Alone For Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: Placebo|DRUG: Docetaxel|DRUG: AG-013736 (axitinib)|DRUG: Docetaxel
Sponsor: Pfizer